FDA approves weight loss drug Zepbound to treat obstructive sleep apnea

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

admin admin
Dec 21, 2024 - 17:00
0 3
FDA approves weight loss drug Zepbound to treat obstructive sleep apnea
The Food and Drug Administration has authorized the use of Zepbound for adults with obesity and moderate to severe obstructive sleep apnea.

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

(Image credit: Getty Images)

Read More